Literature DB >> 12809861

The low prevalence of helicobacter infection in patients with inflammatory bowel disease could be attributed to previous antibiotic treatment.

John K Triantafillidis, Aristofanis Gikas, Nicolaos Apostolidiss, Emmanuel Merikas, Elias Mallass, George Peros.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12809861     DOI： 10.1111/j.1572-0241.2003.07434.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  10 in total

Review 1.  The endoscopic findings of the upper gastrointestinal tract in patients with Crohn's disease.

Authors:  Yoshiki Nomura; Kentaro Moriichi; Mikihiro Fujiya; Toshikatsu Okumura
Journal:  Clin J Gastroenterol       Date:  2017-07-10

2.  Treatment of inflammatory bowel disease patients with anti-TNF-α factors and immunosuppressives does not influence the prevalence of Helicobacter pylori infection.

Authors:  John K Triantafillidis; Aristofanis Gikas; Emmanuel Merikas
Journal:  Indian J Gastroenterol       Date:  2014-07

3.  The relationship between inflammatory bowel disease and Helicobacter pylori across East Asian, European and Mediterranean countries: a meta-analysis.

Authors:  Rabbiaatul Addawiyah Imawana; Daniel Robert Smith; Michaela Louise Goodson
Journal:  Ann Gastroenterol       Date:  2020-06-06

4.  Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease?

Authors:  Christelle Basset; John Holton; Alexandra Bazeos; Dino Vaira; Stuart Bloom
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

Review 5.  Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature.

Authors:  Jay Luther; Maneesh Dave; Peter D R Higgins; John Y Kao
Journal:  Inflamm Bowel Dis       Date:  2010-06       Impact factor: 5.325

Review 6.  Helicobacter pylori infection and inflammatory bowel disease: is there a link?

Authors:  Konstantinos Papamichael; Panagiotis Konstantopoulos; Gerassimos J Mantzaris
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

7.  Helicobacter pylori prevalence and clinical significance in patients with quiescent Crohn's disease.

Authors:  Adi Lahat; Uri Kopylov; Sandra Neuman; Nina Levhar; Doron Yablecovitch; Benjamin Avidan; Batia Weiss; Shomron Ben-Horin; Rami Eliakim
Journal:  BMC Gastroenterol       Date:  2017-02-13       Impact factor: 3.067

8.  Helicobacter pylori may be an initiating factor in newly diagnosed ulcerative colitis patients: A pilot study.

Authors:  Loai Mansour; Ferial El-Kalla; Abdelrahman Kobtan; Sherief Abd-Elsalam; Mohamed Yousef; Samah Soliman; Lobna Abo Ali; Walaa Elkhalawany; Ibrahim Amer; Heba Harras; Maha M Hagras; Mohamed Elhendawy
Journal:  World J Clin Cases       Date:  2018-11-06       Impact factor: 1.337

9.  Hellenic consensus on Helicobacter pylori infection.

Authors:  Sotirios D Georgopoulos; Spyridon Michopoulos; Theodoros Rokkas; Pericles Apostolopoulos; Evangelos Giamarellos; Dimitrios Kamberoglou; Andreas Mentis; Konstantinos Triantafyllou
Journal:  Ann Gastroenterol       Date:  2020-01-07

10.  Gastric lesions in patients with Crohn's disease in Korea: a multicenter study.

Authors:  Hoonsub So; Byong Duk Ye; Young Soo Park; Jihun Kim; Joo Sung Kim; Won Moon; Kang-Moon Lee; You Sun Kim; Bora Keum; Seong-Eun Kim; Kyeong Ok Kim; Eun Soo Kim; Chang Kyun Lee; Sung Pil Hong; Jong Pil Im; Ja Seol Koo; Chang Hwan Choi; Jeong Eun Shin; Bo In Lee; Kyu Chan Huh; Young-Ho Kim; Hyun-Soo Kim; Young Sook Park; Dong Soo Han
Journal:  Intest Res       Date:  2016-01-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.